Recurrent idiopathic iridocyclitis after autologous peripheral blood stem-cell transplantation followed by G-CSF administration for acute lymphoblastic leukemia

J. Tsuchiyama, K. Imajo, N. Sakaguchi, Tadashi Yoshino, N. Suzaki, E. Kondo, N. Kawata, K. Okada, T. Maeda, Y. Tomiyama, T. Tsubota

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We describe a patient who experienced a recurrence of idiopathic iridocyclitis on day 12 after autologous peripheral blood stem-cell transplantation (auto-PBSCT) followed by G-CSF administration for acute lymphoblastic leukemia (ALL). Autologous SCT has been reported to be effective and safe in achieving dose intensification of chemotherapeutic drugs for the treatment of hematopoietic malignancies, but its therapeutic effect on autoimmune diseases is not definite. The findings from the present case suggest that auto-PBSCT followed by G-CSF administration for patients with a history of some kind of autoimmune disorders may induce exacerbation or recurrence of its symptoms after hematopoietic recovery.

Original languageEnglish
Pages (from-to)269-271
Number of pages3
JournalAnnals of Hematology
Volume79
Issue number5
DOIs
Publication statusPublished - Sep 5 1999

Fingerprint

Iridocyclitis
Peripheral Blood Stem Cell Transplantation
Granulocyte Colony-Stimulating Factor
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Recurrence
Therapeutic Uses
Hematologic Neoplasms
Autoimmune Diseases
Pharmaceutical Preparations
Therapeutics

Keywords

  • ALL
  • Auto-PBSCT
  • Recurrent idiopathic iridocyclitis

ASJC Scopus subject areas

  • Hematology

Cite this

Recurrent idiopathic iridocyclitis after autologous peripheral blood stem-cell transplantation followed by G-CSF administration for acute lymphoblastic leukemia. / Tsuchiyama, J.; Imajo, K.; Sakaguchi, N.; Yoshino, Tadashi; Suzaki, N.; Kondo, E.; Kawata, N.; Okada, K.; Maeda, T.; Tomiyama, Y.; Tsubota, T.

In: Annals of Hematology, Vol. 79, No. 5, 05.09.1999, p. 269-271.

Research output: Contribution to journalArticle

Tsuchiyama, J, Imajo, K, Sakaguchi, N, Yoshino, T, Suzaki, N, Kondo, E, Kawata, N, Okada, K, Maeda, T, Tomiyama, Y & Tsubota, T 1999, 'Recurrent idiopathic iridocyclitis after autologous peripheral blood stem-cell transplantation followed by G-CSF administration for acute lymphoblastic leukemia', Annals of Hematology, vol. 79, no. 5, pp. 269-271. https://doi.org/10.1007/s002770050591
Tsuchiyama, J. ; Imajo, K. ; Sakaguchi, N. ; Yoshino, Tadashi ; Suzaki, N. ; Kondo, E. ; Kawata, N. ; Okada, K. ; Maeda, T. ; Tomiyama, Y. ; Tsubota, T. / Recurrent idiopathic iridocyclitis after autologous peripheral blood stem-cell transplantation followed by G-CSF administration for acute lymphoblastic leukemia. In: Annals of Hematology. 1999 ; Vol. 79, No. 5. pp. 269-271.
@article{f0a02a3966b94b688398d44f1c109526,
title = "Recurrent idiopathic iridocyclitis after autologous peripheral blood stem-cell transplantation followed by G-CSF administration for acute lymphoblastic leukemia",
abstract = "We describe a patient who experienced a recurrence of idiopathic iridocyclitis on day 12 after autologous peripheral blood stem-cell transplantation (auto-PBSCT) followed by G-CSF administration for acute lymphoblastic leukemia (ALL). Autologous SCT has been reported to be effective and safe in achieving dose intensification of chemotherapeutic drugs for the treatment of hematopoietic malignancies, but its therapeutic effect on autoimmune diseases is not definite. The findings from the present case suggest that auto-PBSCT followed by G-CSF administration for patients with a history of some kind of autoimmune disorders may induce exacerbation or recurrence of its symptoms after hematopoietic recovery.",
keywords = "ALL, Auto-PBSCT, Recurrent idiopathic iridocyclitis",
author = "J. Tsuchiyama and K. Imajo and N. Sakaguchi and Tadashi Yoshino and N. Suzaki and E. Kondo and N. Kawata and K. Okada and T. Maeda and Y. Tomiyama and T. Tsubota",
year = "1999",
month = "9",
day = "5",
doi = "10.1007/s002770050591",
language = "English",
volume = "79",
pages = "269--271",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Recurrent idiopathic iridocyclitis after autologous peripheral blood stem-cell transplantation followed by G-CSF administration for acute lymphoblastic leukemia

AU - Tsuchiyama, J.

AU - Imajo, K.

AU - Sakaguchi, N.

AU - Yoshino, Tadashi

AU - Suzaki, N.

AU - Kondo, E.

AU - Kawata, N.

AU - Okada, K.

AU - Maeda, T.

AU - Tomiyama, Y.

AU - Tsubota, T.

PY - 1999/9/5

Y1 - 1999/9/5

N2 - We describe a patient who experienced a recurrence of idiopathic iridocyclitis on day 12 after autologous peripheral blood stem-cell transplantation (auto-PBSCT) followed by G-CSF administration for acute lymphoblastic leukemia (ALL). Autologous SCT has been reported to be effective and safe in achieving dose intensification of chemotherapeutic drugs for the treatment of hematopoietic malignancies, but its therapeutic effect on autoimmune diseases is not definite. The findings from the present case suggest that auto-PBSCT followed by G-CSF administration for patients with a history of some kind of autoimmune disorders may induce exacerbation or recurrence of its symptoms after hematopoietic recovery.

AB - We describe a patient who experienced a recurrence of idiopathic iridocyclitis on day 12 after autologous peripheral blood stem-cell transplantation (auto-PBSCT) followed by G-CSF administration for acute lymphoblastic leukemia (ALL). Autologous SCT has been reported to be effective and safe in achieving dose intensification of chemotherapeutic drugs for the treatment of hematopoietic malignancies, but its therapeutic effect on autoimmune diseases is not definite. The findings from the present case suggest that auto-PBSCT followed by G-CSF administration for patients with a history of some kind of autoimmune disorders may induce exacerbation or recurrence of its symptoms after hematopoietic recovery.

KW - ALL

KW - Auto-PBSCT

KW - Recurrent idiopathic iridocyclitis

UR - http://www.scopus.com/inward/record.url?scp=0343673767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0343673767&partnerID=8YFLogxK

U2 - 10.1007/s002770050591

DO - 10.1007/s002770050591

M3 - Article

VL - 79

SP - 269

EP - 271

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

IS - 5

ER -